Works matching IS 17562872 AND DT 2018 AND VI 10 AND IP 2
Results: 5
Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 2, p. 51, doi. 10.1177/1756287217738985
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 2, p. 43, doi. 10.1177/1756287217738150
- By:
- Publication type:
- Article
Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 2, p. 79, doi. 10.1177/1756287217742837
- By:
- Publication type:
- Article
Circulating tumor cells in genitourinary tumors.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 2, p. 65, doi. 10.1177/1756287217742564
- By:
- Publication type:
- Article
Validation of American Joint Committee on Cancer eighth staging system among prostate cancer patients treated with radical prostatectomy.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 2, p. 35, doi. 10.1177/1756287217737706
- By:
- Publication type:
- Article